BioPharma Dive ١١ مايو ٢٠٢٦ Inhibrx delivers ‘differentiated’ cancer drug data; Fractyl starts diabetes gene therapy trial
BioPharma Dive ١١ مايو ٢٠٢٦ Precision in motion: Decoding the critical operations behind the logistics of next-generation cell and gene therapies
BioPharma Dive ٨ مايو ٢٠٢٦ FDA to reevaluate spurned cell therapy; Under-the-skin Leqembi review extended
BioPharma Dive ٧ مايو ٢٠٢٦ Roche to acquire digital pathology firm PathAI in deal potentially worth over $1B